The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010.

Details

Ressource 1Request a copy Sous embargo indéterminé.
State: Public
Version: author
Serval ID
serval:BIB_4A0AB743E9E9
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010.
Journal
Journal of the European Academy of Dermatology and Venereology
Author(s)
van der Leest R.J., de Vries E., Bulliard J.L., Paoli J., Peris K., Stratigos A.J., Trakatelli M., Maselis T.J., Situm M., Pallouras A.C., Hercogova J., Zafirovik Z., Reusch M., Olah J., Bylaite M., Dittmar H.C., Scerri L., Correia O., Medenica L., Bartenjev I., Guillen C., Cozzio A., Bogomolets O.V., del Marmol V.
ISSN
1468-3083 (Electronic)
ISSN-L
0926-9959
Publication state
Published
Issued date
2011
Peer-reviewed
Oui
Volume
25
Number
12
Pages
1455-1465
Language
english
Abstract
Background  Euromelanoma is a skin cancer education and prevention campaign that started in 1999 in Belgium as 'Melanoma day'. Since 2000, it is active in a large and growing number of European countries under the name Euromelanoma. Objective  To evaluate results of Euromelanoma in 2009 and 2010 in 20 countries, describing characteristics of screenees, rates of clinically suspicious lesions for skin cancer and detection rates of melanomas. Methods  Euromelanoma questionnaires were used by 20 countries providing their data in a standardized database (Belgium, Croatia, Cyprus, Czech Republic, FYRO Macedonia, Germany, Greece, Hungary, Italy, Lithuania, Luxembourg, Malta, Moldavia, Portugal, Serbia, Slovenia, Spain, Sweden, Switzerland and Ukraine). Results  In total, 59 858 subjects were screened in 20 countries. Most screenees were female (64%), median ages were 43 (female) and 46 (male) and 33% had phototype I or II. The suspicion rates ranged from 1.1% to 19.4% for melanoma (average 2.8%), from 0.0% to 10.7% for basal cell carcinoma (average 3.1%) and from 0.0% to 1.8% for squamous cell carcinoma (average 0.4%). The overall positive predictive value of countries where (estimation of) positive predictive value could be determined was 13.0%, melanoma detection rates varied from 0.1% to 1.9%. Dermoscopy was used in 78% of examinations with clinically suspected melanoma; full body skin examination was performed in 72% of the screenees. Conclusion  Although the population screened during Euromelanoma was relatively young, high rates of clinically suspected melanoma were found. The efficacy of Euromelanoma could be improved by targeting high-risk populations and by better use of dermoscopy and full body skin examination.
Pubmed
Web of science
Create date
04/10/2011 10:47
Last modification date
20/08/2019 13:57
Usage data